Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
13.66
-0.50 (-3.53%)
At close: Nov 20, 2026, 4:00 PM EST
13.70
+0.04 (0.29%)
After-hours: Nov 20, 2026, 7:30 PM EST
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $1.21 billion as of November 20, 2026. It is the 8,550th most valuable company in the world and the 2,039th biggest in the United States. Its market cap has decreased by 63.71% in one year.
Market Cap
1.21B
Enterprise Value
683.29M
1-Year Change
-63.71%
Global Rank
Country Rank
#2,039 United States
Category
ChartMarket Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $1.21B, an increase of 93.58%. That is a compound annual growth rate of 19.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.21B | -57.88% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 (IPO) | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avalyn Pharma | 1.26B |
| LB Pharmaceuticals | 1.26B |
| MannKind | 1.24B |
| Novavax | 1.23B |
| Silence Therapeutics | 1.23B |
| Generate Biomedicines | 1.23B |
| Ocular Therapeutix | 1.23B |
| Taysha Gene Therapies | 1.21B |